1 transformylase (Tfase) and aminoimidazole-4-carboxamide ribonucleotide (AICAR) Tfase/inosine monophosphate (IMP) cyclohydrolase (ATIC), in the de novo purine biosynthesis pathway have been prime targets for chemotherapeutic development for two main reasons: 1) rapidly dividing tumors rely on purine de novo synthesis for production of adenine and guanine, whereas normal cells prefer the salvage pathway (2), and 2) both proteins are folate-dependent enzymes that can utilize the same cellular folate transport systems that facilitate entry of natural folates into the cell.
ATIC is a bifunctional enzyme that catalyzes the final two steps of the de novo purine biosynthesis pathway (3) . The AICAR transformylase domain (residues 199 -592) catalyzes the transfer of the one-carbon formyl group from the co-factor N 10 -formyl-tetrahydrofolate (10-f-THF) to the substrate AICAR to produce 5-formyl-AICAR and tetrahydrofolate (see Fig. 1A ). The cyclohydrolase domain (residues 1-198) then enhances the intramolecular cyclization of 5-formyl-AICAR to the final product of the pathway, IMP, via elimination of a water molecule. The individual AICAR transformylase and IMP cyclohydrolase domains can be expressed separately and are active (4) .
Previous crystal structures of avian and human ATIC revealed an extensively intertwined homodimer (5-7) (see Fig.  1B ) in which the transformylase and cyclohydrolase active sites were separated by ϳ50 Å. However, no evidence of channeling or tunneling of 5-formyl-AICAR between the two domains has been forthcoming (5, 8) , although strong electropositive patches that connect the two active sites may sequester 5-formyl-AICAR to the vicinity of the binding sites.
Cleland-type kinetic inhibition experiments indicated that the AICAR Tfase reaction is ordered and sequential with folate co-factor binding first to the AICAR Tfase active site (3) . The formyl group is transferred directly from 10-f-THF to AICAR without any formylated enzyme-bound intermediate (9) , as evidenced from crystal structures of avian ATIC in complexes with AICAR (Protein Data Bank entry 1m9n) (6) and a multisubstrate adduct inhibitor (MSA) ␤-DADF (1o20) (7) . From these structures, His 267 was proposed to increase the nucleophilicity of the 5-amino group of AICAR and then act as a catalytic base to deprotonate the AICAR amino group concom-itant with nucleophilic attack of the substrate formyl group on 10-f-THF (6) . Lys 266 is then poised to stabilize the oxyanion transition state and shuttle protons to the N 10 of tetrahydrofolate. The key role of Lys 266 and His 267 in this catalytic mechanism is further supported by kinetic studies of site-directed mutant enzymes (10, 11) , where mutation of Lys 266 and His 267 to alanine results in the complete loss of activity without significant change of the substrate K m (11, 12) . ATIC is highly conserved from Escherichia coli to human but has no sequence homology with other folate-dependent enzymes, such as GAR Tfase. Thus, folate-based inhibitors of GAR Tfase do not usually inhibit ATIC because of differential interactions within the two active sites (7) . For example, 6R-dideazatetrahydrofolate (Lometrexol), potently inhibits GAR Tfase (nM) but not ATIC (M) (13, 14) .
Compared with the number of relatively potent inhibitors of GAR Tfase (15-17, 19 -21) , specific inhibitors of ATIC have been scarce. However, Burroughs Wellcome (Research Triangle Park, NC) has designed and synthesized two antifolates that are specific (nM) for human ATIC, as compared with other folate-dependent enzymes, GAR Tfase, dihydrofolate reductase, and thymidylate synthase. These compounds are both sulfamido-bridged 5,8-dideazafolate analogs identified as BW2315U89UC (BW2315) and BW1540U88UD (BW1540) (see Fig. 1A ) that differ only in the disposition of the imido and sulfonyl groups within the bridge region (see Fig. 1A ). BW1540 and BW2315 have approximate K i values against human ATIC of 8 and 6 nM, respectively, whereas the K i values against GAR Tfase, dihydrofolate reductase and thymidylate synthase are within the micromolar range, except for BW1540, which showed low nanomolar inhibition against dihydrofolate reductase. 2 Cytotoxicity assays against human colon cell lines yielded an approximate IC 50 of 0.7-3 M for BW1540 and 1-5 M for BW2315. To elucidate their mechanism of inhibition, BW1540 and BW2315 were co-crystallized with human ATIC in the presence of substrate AICAR. These first human ATIC ternary complexes with independently bound substrate and folate moieties not only advance the ATIC mechanistic studies but provide insights into the future design of antifolates selective against ATIC.
EXPERIMENTAL PROCEDURES
Materials-Luria broth and agar were obtained from Invitrogen. All common buffers and reagents were purchased from Sigma-Aldrich. The folate-based inhibitors BW1540U88UD and BW2315U89UC were kind gifts from Dr. Robert Ferrone (Burroughs Wellcome).
Protein Preparation and Purification-Human ATIC was prepared as previously reported (22) . Inhibitors BW1540 and BW2315 and substrate AICAR were added in a 10-fold molar excess to human ATIC protein (0.1-0.4 mg/ml), heated in a 37°C water bath for 30 min to prevent precipitation, and then incubated overnight at 4°C. The protein solution was concentrated to 10 mg/ml using Millipore Ultrafree-15 filters (molecular mass of 10,000 Da) and stored at 4°C for crystallization experiments.
Crystallization and Data Collection-Crystals of human ATIC in complex with AICAR and BW1540 were grown at 4°C by sitting drop vapor diffusion by mixing equal volumes of human ATIC (10 mg/ml) and a reservoir solution consisting of 17% polyethylene glycol 3000, 0.1 M Tris, pH 7.5, 10% glycerol, 6 mM dithiothreitol, and 0.1 M NaCl. Streak seeding (23) with apo human ATIC crystals that were produced in similar conditions facilitated growth of needle-shaped crystals. The data were collected to 2.55 Å resolution on a single, flash-cooled crystal at 83 K in a cryoprotectant consisting of mother liquor and 20% glycerol on Beamline 11.1 at the Stanford Synchrotron Radiation Laboratory (Menlo Park, CA). The data were processed to 2.55 Å with HKL2000 (24) in orthorhombic space group P2 1 2 1 2 1 (a ϭ 83.60 Å, b ϭ 93.04 Å, and c ϭ 164.19 Å) ( Table I) . The calculated Matthews' coefficient (V M ϭ 2.5 Å 3 Da Ϫ1 ) suggested two monomers per asymmetric unit (ϳ50% solvent). Crystals of human ATIC in complex with AICAR and BW2315 were similarly produced as described above. The data were collected to 2.6 Å resolution on a single flash-cooled crystal at 106 K on Beamline 5.0.2 at Advanced Light Source (Berkeley, CA). The data were processed with HKL2000 (24) in monoclinic space group P2 1 (a ϭ 77.12 Å, b ϭ 92.97 Å, c ϭ 178.49 Å, and ␤ ϭ 91.19°) ( Table I) . The calculated Matthews' coefficient (V M ϭ 2.5 Å 3 Da Ϫ1 ) suggested four monomers/asymmetric unit (ϳ50% solvent).
Structure Solution and Refinement-The BW1540 and BW2315 complex structures were both determined by molecular replacement using the apo avian ATIC structure (1g8m) (5) as the initial search model. Molecular replacement was performed with EPMR (25) for the BW1540 structure solution, whereas AMoRe (26) was used for the BW2315 complex. For the BW1540 complex, the rotation and translation search, using all data from 15.0 -3.5 Å, identified two monomers in the asymmetric unit with a final correlation co-efficient and R cryst of 55.5 and 44.3%, respectively (note that for the first noise peak, correlation coefficient ϭ 26.4 and R cryst ϭ 56.2%). The two monomers form the biologically relevant homodimer as observed in previous avian ATIC structures (5) (6) (7) . For the BW2315 complex, the rotation search (15.0 -4.0 Å) identified four major solutions with correlation co-efficients of 13.9 -12.1 (noise peak ϭ 8.8); the subsequent translational search yielded a final correlation co-efficient of 60.8 and a R cryst of 39.4%. The four monomers form two biologically relevant homodimers.
Both models were manually built with O (27) and TURBO-FRODO (28) and refined using CNS (29) with cycles of conventional positional refinement and simulated annealing (MLF target). Difference electron density maps clearly identified inhibitors BW1540 and BW2315, as well as an endogenously bound xanthosine 5Ј-monophosphate (XMP), within the AICAR Tfase and IMP cyclohydrolase active sites, respectively. Approximate 2-fold noncrystallographic symmetry restraints were applied during the initial round of refinements and then released later to accommodate differences within the individual monomers. Water molecules were automatically positioned by CNS using a 3 cut-off in F o -F c maps and manually inspected. For the BW1540 structure, the final R cryst and R free are 18.9 and 25.7%, respectively. For the BW2315 structure, the final R cryst and R free are 21.3 and 27.5%, respectively (Table II) .
The models were analyzed with PROCHECK (30), WHATCHECK (31), CNS (29) , and CCP4 (32) . S c co-efficients and buried surface areas were calculated with SC (32) and MS (33) using 1.7 and 1.4 Å probes, respectively. Analysis with PROCHECK (30) revealed that 88.6 and 88.0% of the residues are located in the most favorable regions in the Ramachandran plot for the BW1540 and BW2315 complexes, respectively. In both structures, a surface Asp 502 lies in the disallowed region of the Ramachandran plot, located near the generously allowed region, 2 R. Ferrone, personal communication. 
RESULTS
The crystal structures of human ATIC in complex with antifolates BW1540U88UD and BW2315U89UC provide the first view of how the substrate AICAR and folate-based co-factor moieties simultaneously occupy the AICAR Tfase active site. The AICAR Tfase active site is located in a long, narrow cleft at the dimer interface where AICAR interacts primarily with one subunit and folate with the opposing subunit (7).
The refined human ATIC BW1540 structure consists of residues 4 -592 in monomer A and residues 5-592 in monomer B with 399 water molecules, two potassium ions, two BW1540 inhibitors within the AICAR Tfase domains, but only one XMP in the IMP cyclohydrolase active site of monomer A (Fig. 1B) . XMP is carried through protein purification and crystallization and also selectively binds to only one of the two IMP cyclohydrolase active sites in the homodimer in apo avian and human ATIC structures (5, 22, 36) .
The final model for the BW2315 complex consists of two dimers (i.e. monomers A (4 -592) and B (4 -592) compose one dimer, and monomers C (5-592) and D (4 -592) compose the second dimer) and 388 water molecules. No main chain density was observed between residues 482 and 485 (B), 481-485 (C), and 477-486 (D). Each monomer has a bound potassium ion within the AICAR Tfase domain with only one XMP per dimer (monomers A and C). Interpretable density for the substrate AICAR was found only in monomers B, C, and D, whereas interpretable BW2315 density was found only in monomers B and D. The AICAR Tfase domain contains three subdomains (domains 2-4) as previously described (5-7). For each complex, domain 3 has higher B values (41-47 Å 2 ) compared with the overall protein B values (27-30 Å 2 ) as previously found (6, 7) . AICAR Interactions for Both the BW1540-and BW2315-bound Human ATIC Structures-Clear F o -F c electron density for the AICAR substrate was present in the AICAR Tfase active sites of both complexes, except for monomer A of the BW2315-bound complex structure, which had weak density that could not be unequivocally interpreted. AICAR binds to both complex structures in a similar conformation with a C3Ј-endo sugar pucker (Fig. 2) . The 4-carboxamide amino group of AICAR points toward the aromatic ring of Phe 541Ј with an approximate distance of 3.6 Å to the center of the phenyl ring (Figs. 3A and 4A) as previously described (6, 7) . This -electron hydrogen bond interaction stabilizes the preferred orientation of the 4-carboxamide in which intramolecular hydrogen bonds are formed between the 4-carboxamide amino and the lone pair of N3 electrons, as well as between the 4-carboxamide oxygen and 5-amino group of AICAR. . Interestingly, this Asn 431Ј interaction with the AICAR 5-amino group was not observed in previous structures where its side chain pointed away from the active site (5) (6) (7) 22) . Otherwise, additional active site water molecules are observed in the BW1540 structure that interact with the AICAR phosphate and sugar (Fig. 4) ; the better I/ and completeness of the BW1540 data may account for better quality maps ( Table I ) that facilitate interpretation of these additional waters.
BW1540 Interactions within the AICAR Tfase Active SiteThe primary folate interactions occur with the opposite subunit to that which mainly interacts with AICAR (Figs. 3A and 4A), as previously observed in the ␤-DADF complex structure (7). BW1540 is ϳ78% buried with only 95 Å 2 of its surface exposed to solvent. The 5,8-dideazafolate ring is embedded within hydrophobic environments above and below the ring, whereas hydrophilic interactions are made with its electrophilic substituents around the equator of the ring. (Figs. 3A and 4A ). The Asn 489 interaction was predicted from the ␤-DADF-bound structure but was not observed because of the restrictive covalent trans-double bond between the AICAR and folate moieties (7) . Similarly, Ser 450Ј was proposed to hydrogen bond to the reduced N-5 of the natural co-factor (7). However, as in the ␤-DADF structure, the 5,8-dideazafolate ring is aromatic without a hydrogen bond acceptor for the hydroxyl of Ser 450Ј . The phenyl ring of Phe 544Ј makes a hydrophobic parallel stacking interaction with the 5,8-dideazafolate ring and a potential hydrogen bond with the lone pairs of electrons of the exocyclic 2-amino group (Fig. 3C) .
The imidazole group of AICAR and the p-aminobenzoyl ring of BW1540 stack at a distance between the rings of 4.1 Å in an interaction also not observed in the ␤-DADF-bound structure again because of constrained covalent interaction between the AICAR and folate moieties (7) . The phenyl rings of Phe 590Ј and Phe 315 also provide perpendicular -stacking (3.7 Å) with the AICAR imidazole and p-aminobenzoyl ring of BW1540.
The sulfonyl group of BW1540 is located at the N terminus of ␣-helix 17 (residues 450 -468), suggesting that the helix dipole contributes to stabilizing the partial negative charge of one of the sulfonyl oxygens. A similar interaction was noted with the exocyclic 4-carbonyl of the 8-deazapterin ring of ␤-DADF in the avian MSA structure (7) . The other sulfonyl oxygen hydrogen bonds to the main chain carbonyl of Gln 449Ј and the side chains of Asn 431Ј and Lys 266 (Figs. 3A and 4A ), similar to the hydrogen bonding network seen for the 10-formyl group in the ␤-DADF complex, although the Asn 431Ј interaction was not observed previously. These interactions assist in orienting the Lys 266 side chain and may also facilitate in destabilization of the oxyanion transition state (7) .
The BW1540 glutamate tail orients toward the ATIC surface with two hydrogen bonds from the ␣-glutamate to the side chain of Ser 565Ј and the amide backbone of Ala
566Ј
. The ␥-glutamate forms no protein hydrogen bonds but does orient surface water molecules (Fig. 4A) . Extensive electropositive surface surrounding the active site presumably accounts for binding to the negatively charged ␥-glutamate tail (7), which not only increases cellular retention (37), but also increases affinity for ATIC (38, 39) .
BW2315 Interaction within the AICAR Tfase Active SiteInteractions of BW2315 within the AICAR Tfase active site (monomers B and D) are very similar to those observed in the BW1540 complex structure, except for the complete disorder of the glutamate tail (Fig. 2B) . Although some positive density for BW2315 was observed within the AICAR Tfase active sites of monomers A and C, the inhibitor could not be confidently interpreted. Approximately 87% of the BW2315 surface is buried (41 Å 2 of exposed surface) within the active site, which is slightly larger than the corresponding BW1540 buried surface only because of the inability to observe its solvent-exposed glutamate. Strikingly, superposition of the BW1540 and BW2315 structures reveals that their sulfonyl groups occupy essentially the same location. As a consequence, slight translational and rotational differences of the 5,8-dideazapterin rings are observed within their respective AICAR Tfase active site (Fig. 5A) . The dideazapterin rings are rotated by ϳ15°r elative to each other with a maximum translation of 1.4 Å (as calculated for C-6) (Fig. 5A) . However, the translational differences diminish toward the 2-amino and 4-carboxamide ring substituents to 1.0 and 0.4 Å, respectively, where the BW2315 ring contorts to maximize possible ring substituent interactions, as in BW1540 (Fig. 4) . Similarly, the benzoyl rings of the   FIG. 3 . The AICAR Tfase active site with BW antifolates bound. A, electrostatic and hydrogen bonding residues in the AICAR Tfase active site that interact with antifolate BW1540. BW1540 and ATIC residues are represented in ball-and-stick with BW1540 atoms colored as in Fig. 1B . Carbon atoms for the active site residues are colored blue for subunit A and purple for subunit B of the dimer with structural water molecules represented as red spheres. B, corresponding view of hydrogen bonding residues within the AICAR Tfase active site that interact with AICAR and antifolate BW2315. BW2315 and ATIC residues are represented in ball-and-stick with BW2315 atoms colored as in Fig. 1B . Carbon atoms for the active site residues are colored blue for subunit C and purple for subunit D with structural water molecules represented as red spheres. C, stereo view of the AICAR Tfase active site bound with BW1540 depicts the hydrophobic residues within the folate-binding region. BW1540 and ATIC residues are labeled and colored according to A. two antifolates are displaced from one another by 1.2 Å but with no rotational variation, consistent with the approximate 1.5 Å difference in the disposition of the two sulfonyl groups relative to the C-6 of the dideazapterin (40) . Because both sulfonyl groups of BW1540 and BW2315 sit atop the N terminus of ␣-helix 17, the stabilization of the partial negative charge of the sulfonyl oxygen by the helix dipole appears to be the driving force that defines the binding and orientation of the (6) and ␤-DADF (7) but also provide new information on how the AICAR and folate moieties are oriented in the ternary complex. The most surprising observation is the domination of the active site oxyanion hole in determining the location and orientation of these bound sulfonyl-based antifolates.
Conformational Changes in the AICAR Tfase Active SiteSuperposition of the AICAR/BW1540-and AICAR/BW2315-bound human ATIC structures with the apo human ATIC structure (1pkx) (22) (main chain root mean square deviation values of 0.92 and 0.54 Å, respectively) reveal that the AICAR Tfase active site itself is relatively rigid. Nevertheless, some local conformational rearrangements of some side chains, as well as the abutting main chain, tend to constrict the AICAR Tfase active site around the bound inhibitor (Fig. 5B) . The side chains of Arg 207 , Tyr 208 , and Phe 541Ј slightly reorient so as to interact optimally with the substrate AICAR (Fig. 5B) , and Ser 565Ј reposition toward the pterin ring of the folate inhibitors. Main chain movements are observed in two of the ␣-helices within the AICAR Tfase active site. The ␣-helix 17 (residues 450 -468) that anchors the sulfonyl oxygens has an average displacement of 1.2 Å, whereas ␣-helix 23 that interacts with the ␣-glutamate is displaced by an average of 1.5 Å (Fig. 5B) . ␤-DADF (1o20) (7) (main chain root mean square deviations of only 1.1 and 1.0 Å, respectively). However, the substrate and folate ligand positions vary somewhat, mainly because of the binding of independent AICAR and folate moieties in the BW1540 and BW2315 human structures compared with the equivalent moieties that are covalently tethered in the MSA in the avian structure. The imidazole ring of the AICAR moiety of ␤-DADF is slightly rotated and translated away from the folate ring by ϳ1 Å with respect to the untethered AICAR molecules the human complexes. Similarly, the tethered pterin ring of ␤-DADF is rotated by 40°and translated out of the folatebinding region by about 2 Å compared with the 5,8-dideazapterin of the BW compounds (Fig. 6A) , and Asn
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. The more limited interactions of ␤-DADF within the active site may explain why main chain conformational changes were not observed as with the BW compounds. However, despite these fluctuations in the folate ring position, the 10-carbonyl of ␤-DADF (equivalent to the N 10 formyl group) superimposes remarkably closely with the sulfonyl oxygen atoms of both BW inhibitors within the oxyanion hole so that similar interactions are made with the catalytic Lys 266 . The BW inhibitors and ␤-DADF all have an aromatic 5,8-dideazapterin ring substituted for the naturally reduced pterin of 10-f-THF that results in loss potential hydrogen bond interactions with active site residues, such as the potential N-8 interaction of the natural co-factor with the main chain carbonyl of Met 312 and the Ser 450Ј hydroxyl, as well as with a main chain amide interaction of Arg 451Ј with N-5. Further, the aromatic dideazapterin adopts a rigid ring conformation compared with the reduced pterin, which is more flexible and can mold better to the active site to optimize electrophilic interactions.
Role of Asn 431Ј in Catalysis-In previous avian ATIC structures, the Asn 431Ј side chain pointed away from the active site. In the ␤-DADF structure, the likely role for Asn 431Ј was to position active site waters for interaction with the AICAR 4-carboxamide oxygen and the N 10 formyl group (7). The BW1540 and BW2315 structures reveal that Asn 431Ј may in fact play a greater role than anticipated where it now interacts directly with both AICAR and folate (Fig. 6B) ; its side chain carboxamide provides electrostatic interactions with the AICAR 5-amino group and one of the folate sulfonyl oxygens (Figs. 4 and 6B) . Asn 431Ј is also now positioned within hydrogen bonding distance of N⑀2 of His 267 , which may be important for the concerted action of these two residues in formyl transfer.
Active site asparagine residues are found in a variety of proteins, and their general role is to fine-tune the positions of substrates and/or catalytic side chains. For example, GAR (42, 43) . The class III anaerobic ribonucleotide reductase from bacteriophage T4 has two asparagine residues within its active site that are proposed to position the substrate formate to orient it toward the proposed thiyl radical of the catalytic residues Cys 79 (44 , with distances of 2.8, 2.8, and 2.9 Å in the BW1540 complex, respectively.
Role of the Oxyanion Hole in Positioning the 10-Formyl Group of Natural Co-factor-Superposition of the BW inhibitor sulfonyl oxygens and the ␤-DADF 10-formyl oxygen also suggests that one of the primary determinants for the inhibitor positioning within the active site stems from the interaction with the oxyanion hole composed of main chain amides from the N terminus of the adjacent ␣-helix (residues 450 -468) (note that BW1540 and ␤-DADF oxygens are separated by only 0.9 Å, the BW1540 and BW2315 oxygens are separated by 1.1 Å, and BW2315 and ␤-DADF oxygens are separated by 0.8 Å). Oxyanion holes that primarily consist of two main chain amides are a common active site feature for stabilizing transition state intermediates in various enzymes, including all known ␣/␤ hydrolase family members (18, 45) . The sulfonyl oxygen of BW1540 is situated closer to the main chain nitrogen atoms of Ser 450Ј and Arg 451Ј compared with BW2315, in which the nitrogen (at position 9) is inserted between the sulfonyl and the 5,8-dideazapterin ring (Figs. 1A and 5A) . Nevertheless, the dideazapterin ring substituents of these two BW inhibitors maintain similar hydrogen bonds and bond lengths with active site residues.
On the other hand, the reduced folate ring of the natural co-factor is able to provide additional functional groups for hydrogen bonding within the active site that may then further influence co-factor binding as compared with the dominant interaction of the sulfonyl compounds with the oxyanion hole. Distances between the AICAR 5-amino nitrogen and the closest sulfonyl oxygens of the BW1540 and BW2315 structures are 3.5 and 2.6 Å, respectively, which are too far for nucleophilic attack if the BW2315 sulfonyl oxygen is considered to be functionally equivalent to the less electrophilic 10-formyl carbon of 10-f-THF (Fig. 1A) . Similarly, in the ␤-DADF-bound structure, despite the covalent bond between the 10-formyl group and the AICAR 5-methenyl (equivalent to the 5-amino of 10-f-THF) that includes an additional 1.5 Å spacer because of the extra double bond linker (7), the formyl carbonyl position of ␤-DADF is maintained within the oxyanion hole. However, in the natural co-factor, the additional potential hydrogen bond interactions with the AICAR Tfase active site, the weaker electron withdrawing effects of the 10-formyl oxygen, the ability of the Lys 266 side chain to stabilize the oxyanion transition state without steric hindrance from other active site residues (6, 7), and the presence of Asn 431Ј to fine-tune the distance between the two groups could facilitate motion of the 10-formyl group of 10-f-THF away from the oxyanion hole toward the AICAR 5-amino for covalent bond formation.
ATIC-specific Antifolate Inhibitor Design-The BW1540 and BW2315 ATIC complex structures indicate that the oxyanion hole appears to be a major factor determining the positioning of the sulfonyl-containing antifolates within the AICAR Tfase active site. Thus, further ATIC antifolate design should focus on exploiting this oxyanion hole because GAR Tfase, thymidylate synthase, and dihydrofolate reductase do not contain such a feature within their active sites. Although the sulfonyl groups should be conserved in the next generation of inhibitors, they should be positioned as true mimics of the 10-formyl group between the pterin and benzyl rings to emulate the actual transition state. Then the aromatic 5,8-dideazapterin ring should be substituted with the natural, reduced pterin to exploit additional active site interactions that probably require some modest reconfiguration of the folate-binding site. Substitution for the reduced pterin ring may also aid in reduced folate carrier and folylpoly-␥-glutamate synthetase recognition, thereby facilitating active transport across the cell membrane and polyglutamation, respectively. Strong electronegative substituents, such as a nitrile functional group, should also be evaluated in place of the sulfonyl. This substitution would not only be optimal for utilization of the oxyanion hole interactions but also aid in possible formation of an in vivo covalent multisubstrate adduct inhibitor.
Active Site Conservation in Avian and Other OrganismsThe overall structure of human ATIC is highly homologous to the avian ATIC structure as expected from the high sequence identity (82% (Fig. 7) . Only three differences are found within the AICAR Tfase active site. Asp 339 has a conservative mutation to glutamate in E. coli and Synechocystis sp. that could still maintain hydrogen bonding with the AICAR ribose O-3. However, an equivalent residue to Asn 489 is not present in bacterial sequences because the entire domain 3 (residues 468 -531) is deleted (Fig. 7) . Otherwise, the Asn 547Ј mutation to a glycine and serine in E. coli and Synechocystis sp., respectively, would likely reduce interactions with the exocyclic substituents of the pterin ring.
In addition to these conserved electrophilic active site residues, the hydrophobic pockets are also well preserved. Phe 315 , Pro , which interact with the imidazole of AICAR, the benzoyl of folate, and the 5,8-dideazapterin ring of folate, are completely conserved across the seven sequences. Met 312 and Ile 452Ј that form the bottom hydrophobic patch of the folate binding pocket are conserved in eukaryotes but mutated to threonine and valine in bacterial sequences. However, if the hydroxyl of threonine in bacterial ATIC points away from the folate binding pocket, it could still otherwise provide some hydrophobic contacts. Interestingly, a stretch of seven residues from Ser 538Ј to Phe 544Ј is completely conserved across the seven organisms and contains Phe 541Ј , which is involved in the AICAR 4-carboxamide interaction and Pro 543Ј and Phe
544Ј
, both of which provide a hydrophobic environment for the pterin ring of folate. Conclusion-The crystal structures of human ATIC complexed with these sulfonyl-containing Burroughs Wellcome inhibitors BW1540 and BW2315, as well as substrate AICAR, provide the first details of an AICAR Tfase ternary complex. Moreover, interaction of the sulfonyl oxygens with the oxyanion hole of the AICAR Tfase active site suggests that this is the driving force behind the high affinity for these sulfonyl-containing antifolates. The K m of 10-f-THF is 100 M (8), whereas the K i values for BW1540 and BW2315 are 8 and 6 nM, respectively. Thus, these two antifolates bind more strongly to the AICAR Tfase active site, by at least 1000-fold, compared with the natural co-factor that is probably due to the sulfonyl groups mimicking to some extent the oxyanion of the transition state. However, substitution of the reduced pterin ring for the 5,8- dideazapterin analog in the BW compounds suggests that design of more potent inhibitors could arise from increased interactions with the folate-binding site. Nevertheless, inhibitor interactions with the unique oxyanion hole of ATIC, which dominates the binding of these sulfonyl antifolates, could be further exploited for the next generation of selective ATIC antifolates.
